These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 16797329

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G.
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [Abstract] [Full Text] [Related]

  • 4. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G.
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [Abstract] [Full Text] [Related]

  • 5. Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.
    Atamaz F, Hepguler S, Akyildiz M, Karasu Z, Kilic M.
    Osteoporos Int; 2006 Jan; 17(6):942-9. PubMed ID: 16550299
    [Abstract] [Full Text] [Related]

  • 6. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.
    Shane E, Addesso V, Namerow PB, McMahon DJ, Lo SH, Staron RB, Zucker M, Pardi S, Maybaum S, Mancini D.
    N Engl J Med; 2004 Feb 19; 350(8):767-76. PubMed ID: 14973216
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alendronate prevents further bone loss in renal transplant recipients.
    Giannini S, D'Angelo A, Carraro G, Nobile M, Rigotti P, Bonfante L, Marchini F, Zaninotto M, Dalle Carbonare L, Sartori L, Crepaldi G.
    J Bone Miner Res; 2001 Nov 19; 16(11):2111-7. PubMed ID: 11697808
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
    Wiernikowski JT, Barr RD, Webber C, Guo CY, Wright M, Atkinson SA.
    J Oncol Pharm Pract; 2005 Jun 19; 11(2):51-6. PubMed ID: 16460605
    [Abstract] [Full Text] [Related]

  • 12. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
    Gallagher JC, Rosen CJ, Chen P, Misurski DA, Marcus R.
    Bone; 2006 Dec 19; 39(6):1268-75. PubMed ID: 16884968
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK, Chadha M, Modi KD, Kumar KM, Mehrotra R, Sriram U.
    J Assoc Physicians India; 2008 Jun 19; 56():418-24. PubMed ID: 18822620
    [Abstract] [Full Text] [Related]

  • 14. Alendronate treatment in osteogenesis imperfecta.
    Madenci E, Yilmaz K, Yilmaz M, Coskun Y.
    J Clin Rheumatol; 2006 Apr 19; 12(2):53-6. PubMed ID: 16601536
    [Abstract] [Full Text] [Related]

  • 15. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
    Skordis N, Ioannou YS, Kyriakou A, Savva SC, Efstathiou E, Savvides I, Christou S.
    Pediatr Endocrinol Rev; 2008 Oct 19; 6 Suppl 1():144-8. PubMed ID: 19337169
    [Abstract] [Full Text] [Related]

  • 16. Alendronate in the prevention of bone loss after a fracture of the lower leg.
    van der Poest Clement E, van Engeland M, Adèr H, Roos JC, Patka P, Lips P.
    J Bone Miner Res; 2002 Dec 19; 17(12):2247-55. PubMed ID: 12469919
    [Abstract] [Full Text] [Related]

  • 17. Alendronate is effective to treat bone loss in renal transplantation recipients.
    Lan G, Peng L, Xie X, Peng F, Wang Y, Yu S.
    Transplant Proc; 2008 Dec 19; 40(10):3496-8. PubMed ID: 19100422
    [Abstract] [Full Text] [Related]

  • 18. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men.
    Guven Z, Karadag-Saygi E, Unlu-Ozkan F, Akyuz G.
    Aging Male; 2007 Dec 19; 10(4):197-201. PubMed ID: 18033629
    [Abstract] [Full Text] [Related]

  • 19. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
    Walsh SB, Altmann P, Pattison J, Wilkie M, Yaqoob MM, Dudley C, Cockwell P, Sweny P, Banks LM, Hall-Craggs M, Noonan K, Andrews C, Cunningham J.
    Am J Kidney Dis; 2009 May 19; 53(5):856-65. PubMed ID: 19393473
    [Abstract] [Full Text] [Related]

  • 20. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S, Broy S, Kaiser F, Teutsch C, Rosenberg E, DeLucca P, Melton M.
    Curr Med Res Opin; 2007 Jun 19; 23(6):1341-9. PubMed ID: 17594775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.